SCHEMBL3254375

SCHEMBL3254375

CC(C)(C)OC(=O)Nc1cccc(-c2ccc3[nH]c(=O)c4[nH]cc(OC(=O)O)c4c3c2)c1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP17A1 P05093 1/20 0.44
JAK2 O60674 1/20 0.41
BRD4 O60885 2/20 0.39
CREBBP Q92793 1/20 0.39
GABRA1 P14867 1/20 0.37
GABRG2 P18507 1/20 0.37
GABRB3 P28472 1/20 0.37
GABRA5 P31644 1/20 0.37
GABRA3 P34903 1/20 0.37
GABRA2 P47869 1/20 0.37
GABRA6 Q16445 1/20 0.37
HDAC1 Q13547 4/20 0.36
HDAC4 P56524 2/20 0.36
HDAC3 O15379 3/20 0.35
HDAC2 Q92769 3/20 0.35
HDAC10 Q969S8 3/20 0.35
HDAC8 Q9BY41 3/20 0.35
SCN9A Q15858 2/20 0.35
SCN3A Q9NY46 2/20 0.35
SCN4A P35499 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3243042 0.89 CYP17A1 (0.41) CYP17A1JAK2BRD4CREBBPHDAC1
SCHEMBL3251493 0.88 CYP17A1 (0.45) CYP17A1JAK2BRD4CREBBPGABRA1
SCHEMBL4155388 0.84 CYP17A1 (0.42) CYP17A1JAK2BRD4CREBBPGABRA1
SCHEMBL3249904 0.82 JAK3 (0.44) CYP17A1JAK2
SCHEMBL3251646 0.81 MAP4K4 (0.40) CYP17A1JAK2BRD4CREBBPHDAC1
SCHEMBL4713726 0.81 CYP17A1 (0.48) CYP17A1JAK2BRD4CREBBPGABRA1
SCHEMBL3245555 0.79 MAP4K4 (0.44) CYP17A1JAK2BRD4CREBBPGABRA1
Propionic Acid SCHEMBL4155395 0.78 CYP17A1 (0.44) CYP17A1JAK2BRD4CREBBPGABRA1
SCHEMBL3252205 0.78 TTK (0.42) CYP17A1MAP4K4
SCHEMBL4166406 0.75 MAP4K4 (0.41) CYP17A1JAK2GABRA1GABRG2GABRB3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1899335-B1 PYRROLOQUINOLINE DERIVATIVES AND THEIR USE AS PROTEIN KINASE INHIBITORS PF MEDICAMENT (FR) 2010-05-19 EP disclosed